Pathology & Laboratory Medicine

Warning message

Selective filter "Related Faculty (field_biblio_faculty) (selective)" has limited the amount of total results. Please, review you query configuration.

Publications

Filter By Faculty

Filter by Principal Investigator

1993

Garrett TJ, Chadburn A, Barr ML, Drusin RE, Chen JM, Schulman LL, et al. Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy. Cancer. 1993;72(9):2782-5.

Truter S, Andrikopoulos K, Di Liberto M, Womack L, Ramirez F. Pro-alpha 2(V) collagen gene; pairwise analysis of the amino-propeptide coding domain, and cross-species comparison of the promoter sequence. Connect Tissue Res. 1993;29(1):51-9.

Ngadiman S, Whitney K, Godwin TA, Zuna R, Goldfarb AB, Hoda SA. Squamous cell carcinoma of the breast. South Med J. 1993;86(6):716-7.

Diaz-Meco MT, Berra E, Municio MM, Sanz L, Lozano J, Dominguez I, et al. A dominant negative protein kinase C zeta subspecies blocks NF-kappa B activation. Mol Cell Biol. 1993;13(8):4770-5.

Neustein SM, Bronheim D, Galla J, Litwak R, Rand J, Scott BH, et al. Case 1--1993. The role of erythropoietin in Jehovah's Witnesses requiring cardiac surgery. J Cardiothorac Vasc Anesth. 1993;7(1):95-102.

Exposito JY, D'Alessio M, Di Liberto M, Ramirez F. Complete primary structure of a sea urchin type IV collagen alpha chain and analysis of the 5' end of its gene. J Biol Chem. 1993;268(7):5249-54.

Falcone DJ, McCaffrey TA, Haimovitz-Friedman A, Vergilio JA, Nicholson AC. Macrophage and foam cell release of matrix-bound growth factors. Role of plasminogen activation. J Biol Chem. 1993;268(16):11951-8.

Dominguez I, Sanz L, Arenzana-Seisdedos F, Diaz-Meco MT, Virelizier JL, Moscat J. Inhibition of protein kinase C zeta subspecies blocks the activation of an NF-kappa B-like activity in Xenopus laevis oocytes. Mol Cell Biol. 1993;13(2):1290-5.

Harris PE, Maffei A, Liu Z, Colovai I, Reed EF, Inghirami G, et al. Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol. 1993;151(11):5975-83.

Chavin KD, Qin L, Lin J, Kaplan AJ, Bromberg JS. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects. Transplantation. 1993;55(4):901-8.